LYRCX | VMVAX | LYRCX / VMVAX | |
Total Expense Ratio | 1.99 | 0.07 | 2,843% |
Annual Report Gross Expense Ratio | 2.46 | 0.07 | 3,514% |
Fund Existence | 3 years | 14 years | - |
Gain YTD | -4.576 | -5.253 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 922M | 29.9B | 3% |
Annual Yield % from dividends | 0.00 | 2.33 | - |
Returns for 1 year | 0.37 | 2.10 | 18% |
Returns for 3 years | N/A | 4.97 | - |
Returns for 5 years | N/A | 76.23 | - |
Returns for 10 years | N/A | 69.17 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LABU | 56.25 | 3.47 | +6.57% |
Direxion Daily S&P Biotech Bull 3X ETF | |||
EUDG | 33.42 | 0.44 | +1.33% |
WisdomTree Europe Quality Div Gr ETF | |||
EWU | 37.89 | 0.34 | +0.91% |
iShares MSCI United Kingdom ETF | |||
HCOM | 15.45 | 0.09 | +0.59% |
Hartford Schroders Commodity Strtgy ETF | |||
EHI | 6.34 | 0.02 | +0.32% |
Western Asset Global High Income Fund |